AKOUOS

drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; biologics and small molecules in the nature Read More

Classification Information

Class [5]
Pharmaceutical Products

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; biologics and small molecules in the nature of pharmaceutical preparations for use in treating diseases and conditions involving the ear in the nature of genetic conditions causing hearing loss; gene therapy products to restore, improve, and preserve hearing; gene therapy products to treat inner ear disorders and conditions; viral vectors, non-viral vectors, gene therapy vectors all for medical purposes in gene therapy for inner ear disorders and conditions; biotechnological platform technology, namely, biological nanoparticles and adenoviruses for gene delivery to biological cells that includes adeno-associated viral (AAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to restore, improve and preserve hearing; biotechnological platform technology, namely, biological nanoparticles and adenoviruses for gene delivery to biological cells that includes adeno-associated viral (AAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to treat inner ear disorders and conditions.

Class [10]
Medical Instrument Products

Drug delivery systems; viral vector delivery platforms for gene therapy; medical devices for use in treating diseases and conditions involving the ear in the nature of genetic conditions causing hearing loss.

Class [42]
Computer & Software Services & Scientific Services

Scientific research consulting in the field of inner ear disorders and conditions and hearing loss; custom development of biochemical reagents and biological nanoparticles, namely, therapeutic compositions that include adeno-associated viral (AAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to restore, improve and preserve hearing; custom development of biochemical reagents and biological nanoparticles, namely, therapeutic compositions that include adeno-associated viral (AAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to treat inner ear disorders and conditions.

Class [44]
Medical, Beauty & Agricultural Services

Providing a website in relation to education information regarding inner ear disorders and conditions, hearing loss and genetics.

Mark Details

Serial Number

UK00003640692

Mark Type

Figurative

Kind of mark

Individual